One study indicated that shR-GAL3-treated melanoma cells exhibit a high level of accumulated LC3-II compared to melanoma cells expressing GAL3, resulting in an increased autophagy flux rate (Bustos et al., 2018). The gene discussed is LGALS3; the disease is melanoma.